ZyVersa Therapeutics, Inc
ZyVersa Therapeutics Inc., based in Fort Lauderdale, FL, is dedicated to transforming health outcomes and enhancing quality of life for patients suffering from inflammatory and renal diseases. The company is focused on developing innovative treatments, such as IC 100, a monoclonal antibody targeting inflammasome components, and VAR 200, a cholesterol efflux mediator aimed at improving kidney function.
Through their cutting-edge research on inflammasomes and renal lipids, ZyVersa is committed to addressing critical health challenges related to obesity, metabolic inflammatory diseases, and chronic kidney conditions. Their advanced therapeutic pipeline underscores a mission to restore health and promote well-being for affected individuals.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.